Se
Non verificato

Seaport Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaPsichiatriaSaluteScienza
09/09/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
1.00
03/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Igiene alimentare
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
1.00
08/06/2026
Mercato azionario
Psichiatria
Salute
Scienza
Farmaceutica
Biotecnologia
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
1.00
01/06/2026
Eventi
Web e Social Network
Psichiatria
Salute
Scienza
Farmaceutica
Biotecnologia
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
1.00
01/05/2026
Titoli e azioni
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0